Last mentioned: Mar 6, 2026
Initial Expiration
The first six-month period ends, pending potential CMS extension.
Initial Expiration
CMS will evaluate whether to lift the moratorium or extend it for another six months.
Initial Expiration
The first six-month period ends, at which point CMS may choose to extend the moratorium.
Moratorium Effective Date
Nationwide freeze on new DMEPOS enrollments officially begins.
Moratorium Effective Date
Nationwide freeze on new DMEPOS enrollments officially begins.
Moratorium Effective
CMS officially publishes the notice and the nationwide enrollment freeze begins immediately.
Data Review Period Ends
CMS concludes a multi-year review of high-risk enrollment and claims data.
Data Review Period Ends
CMS concludes a review showing a 17% spike in DMEPOS enrollment and claims activity.
Data Review Concludes
CMS finishes a multi-year review of Medicare enrollment and claims data identifying high-risk trends.
OIG Fraud Warning
HHS OIG highlights over a decade of concerns regarding DME supplier fraud.
OIG Fraud Report
HHS OIG highlights billions in potentially improper Medicare payments to DME suppliers.
OIG Fraud Warning
HHS OIG highlights billions in improper DME payments over the previous decade.
The Centers for Medicare & Medicaid Services (CMS) has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory move, effective February 27, 2026, aims to curb systemic fraud and billions in improper payments within the DMEPOS sector.
The Centers for Medicare & Medicaid Services has implemented a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. Effective February 27, 2026, this aggressive regulatory action aims to curb systemic fraud and improper payments within the DMEPOS sector.
The Centers for Medicare & Medicaid Services (CMS) has enacted a six-month nationwide freeze on new Medicare enrollments for seven categories of medical supply companies. This aggressive regulatory action, effective February 27, 2026, aims to curb systemic fraud and improper billing within the DMEPOS sector.